Close Menu

NEW YORK – Emerald Organic Products and Todos Medical said Tuesday that they have formed a joint venture, Corona Diagnostics, to provide screening assays and diagnostic tests for COVID-19 in the US.

Financial and other terms of the deal were not disclosed.

Emerald Organic, a diversified health sciences company, will contribute financing, US domestic distribution know-how, international trade relationships, and assistance in navigating the US healthcare and regulatory landscape, the firms said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The head of Operation Warp Speed tells Bloomberg he expects the paused AstraZeneca and Johnson & Johnson vaccine trials to resume soon.

A new UK government says socioeconomic factors, not genetics, account for disparities in deaths due to COVID-19 between ethnic groups, the Financial Times reports.

NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.

In Nature this week: CRISPR-Cas3 system for making large deletions efficiently, more.

Nov
10
Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.